Report Detail
COVID-19 Impact on Global Prophylactic Human Vaccine, Market Insights and Forecast to 2026
- RnM4073314 |
- 23 June, 2020 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Prophylactic Human Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prophylactic Human Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Prophylactic Human Vaccine market is segmented into
Inactivated Vaccine
Attenuated Vaccine
Others
Segment by Application, the Prophylactic Human Vaccine market is segmented into
Hospital
Scientific Research
Others
Regional and Country-level Analysis
The Prophylactic Human Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Prophylactic Human Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Prophylactic Human Vaccine Market Share Analysis
Prophylactic Human Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prophylactic Human Vaccine business, the date to enter into the Prophylactic Human Vaccine market, Prophylactic Human Vaccine product introduction, recent developments, etc.
The major vendors covered:
GSK
Biovac
McKesson Medical
Merck
Merial
Zoetis
Sanofi
...
1 Study Coverage
- 1.1 Prophylactic Human Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key Prophylactic Human Vaccine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Prophylactic Human Vaccine Market Size Growth Rate by Type
- 1.4.2 Inactivated Vaccine
- 1.4.3 Attenuated Vaccine
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global Prophylactic Human Vaccine Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Scientific Research
- 1.5.4 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Prophylactic Human Vaccine Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Prophylactic Human Vaccine Industry
- 1.6.1.1 Prophylactic Human Vaccine Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Prophylactic Human Vaccine Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Prophylactic Human Vaccine Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Prophylactic Human Vaccine Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Prophylactic Human Vaccine Market Size Estimates and Forecasts
- 2.1.1 Global Prophylactic Human Vaccine Revenue 2015-2026
- 2.1.2 Global Prophylactic Human Vaccine Sales 2015-2026
- 2.2 Prophylactic Human Vaccine Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Prophylactic Human Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Prophylactic Human Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Prophylactic Human Vaccine Competitor Landscape by Players
- 3.1 Prophylactic Human Vaccine Sales by Manufacturers
- 3.1.1 Prophylactic Human Vaccine Sales by Manufacturers (2015-2020)
- 3.1.2 Prophylactic Human Vaccine Sales Market Share by Manufacturers (2015-2020)
- 3.2 Prophylactic Human Vaccine Revenue by Manufacturers
- 3.2.1 Prophylactic Human Vaccine Revenue by Manufacturers (2015-2020)
- 3.2.2 Prophylactic Human Vaccine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Prophylactic Human Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Prophylactic Human Vaccine Revenue in 2019
- 3.2.5 Global Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Prophylactic Human Vaccine Price by Manufacturers
- 3.4 Prophylactic Human Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Prophylactic Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Prophylactic Human Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Prophylactic Human Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Prophylactic Human Vaccine Market Size by Type (2015-2020)
- 4.1.1 Global Prophylactic Human Vaccine Sales by Type (2015-2020)
- 4.1.2 Global Prophylactic Human Vaccine Revenue by Type (2015-2020)
- 4.1.3 Prophylactic Human Vaccine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Prophylactic Human Vaccine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Prophylactic Human Vaccine Sales Forecast by Type (2021-2026)
- 4.2.2 Global Prophylactic Human Vaccine Revenue Forecast by Type (2021-2026)
- 4.2.3 Prophylactic Human Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Prophylactic Human Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Prophylactic Human Vaccine Market Size by Application (2015-2020)
- 5.1.1 Global Prophylactic Human Vaccine Sales by Application (2015-2020)
- 5.1.2 Global Prophylactic Human Vaccine Revenue by Application (2015-2020)
- 5.1.3 Prophylactic Human Vaccine Price by Application (2015-2020)
- 5.2 Prophylactic Human Vaccine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Prophylactic Human Vaccine Sales Forecast by Application (2021-2026)
- 5.2.2 Global Prophylactic Human Vaccine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Prophylactic Human Vaccine Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Prophylactic Human Vaccine by Country
- 6.1.1 North America Prophylactic Human Vaccine Sales by Country
- 6.1.2 North America Prophylactic Human Vaccine Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Prophylactic Human Vaccine Market Facts & Figures by Type
- 6.3 North America Prophylactic Human Vaccine Market Facts & Figures by Application
7 Europe
- 7.1 Europe Prophylactic Human Vaccine by Country
- 7.1.1 Europe Prophylactic Human Vaccine Sales by Country
- 7.1.2 Europe Prophylactic Human Vaccine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Prophylactic Human Vaccine Market Facts & Figures by Type
- 7.3 Europe Prophylactic Human Vaccine Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Prophylactic Human Vaccine by Region
- 8.1.1 Asia Pacific Prophylactic Human Vaccine Sales by Region
- 8.1.2 Asia Pacific Prophylactic Human Vaccine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Prophylactic Human Vaccine Market Facts & Figures by Type
- 8.3 Asia Pacific Prophylactic Human Vaccine Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Prophylactic Human Vaccine by Country
- 9.1.1 Latin America Prophylactic Human Vaccine Sales by Country
- 9.1.2 Latin America Prophylactic Human Vaccine Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Prophylactic Human Vaccine Market Facts & Figures by Type
- 9.3 Central & South America Prophylactic Human Vaccine Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Prophylactic Human Vaccine by Country
- 10.1.1 Middle East and Africa Prophylactic Human Vaccine Sales by Country
- 10.1.2 Middle East and Africa Prophylactic Human Vaccine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Prophylactic Human Vaccine Market Facts & Figures by Type
- 10.3 Middle East and Africa Prophylactic Human Vaccine Market Facts & Figures by Application
11 Company Profiles
- 11.1 GSK
- 11.1.1 GSK Corporation Information
- 11.1.2 GSK Description, Business Overview and Total Revenue
- 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GSK Prophylactic Human Vaccine Products Offered
- 11.1.5 GSK Recent Development
- 11.2 Biovac
- 11.2.1 Biovac Corporation Information
- 11.2.2 Biovac Description, Business Overview and Total Revenue
- 11.2.3 Biovac Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Biovac Prophylactic Human Vaccine Products Offered
- 11.2.5 Biovac Recent Development
- 11.3 McKesson Medical
- 11.3.1 McKesson Medical Corporation Information
- 11.3.2 McKesson Medical Description, Business Overview and Total Revenue
- 11.3.3 McKesson Medical Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 McKesson Medical Prophylactic Human Vaccine Products Offered
- 11.3.5 McKesson Medical Recent Development
- 11.4 Merck
- 11.4.1 Merck Corporation Information
- 11.4.2 Merck Description, Business Overview and Total Revenue
- 11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Merck Prophylactic Human Vaccine Products Offered
- 11.4.5 Merck Recent Development
- 11.5 Merial
- 11.5.1 Merial Corporation Information
- 11.5.2 Merial Description, Business Overview and Total Revenue
- 11.5.3 Merial Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Merial Prophylactic Human Vaccine Products Offered
- 11.5.5 Merial Recent Development
- 11.6 Zoetis
- 11.6.1 Zoetis Corporation Information
- 11.6.2 Zoetis Description, Business Overview and Total Revenue
- 11.6.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Zoetis Prophylactic Human Vaccine Products Offered
- 11.6.5 Zoetis Recent Development
- 11.7 Sanofi
- 11.7.1 Sanofi Corporation Information
- 11.7.2 Sanofi Description, Business Overview and Total Revenue
- 11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Sanofi Prophylactic Human Vaccine Products Offered
- 11.7.5 Sanofi Recent Development
- 11.1 GSK
- 11.1.1 GSK Corporation Information
- 11.1.2 GSK Description, Business Overview and Total Revenue
- 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GSK Prophylactic Human Vaccine Products Offered
- 11.1.5 GSK Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Prophylactic Human Vaccine Market Estimates and Projections by Region
- 12.1.1 Global Prophylactic Human Vaccine Sales Forecast by Regions 2021-2026
- 12.1.2 Global Prophylactic Human Vaccine Revenue Forecast by Regions 2021-2026
- 12.2 North America Prophylactic Human Vaccine Market Size Forecast (2021-2026)
- 12.2.1 North America: Prophylactic Human Vaccine Sales Forecast (2021-2026)
- 12.2.2 North America: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
- 12.2.3 North America: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026)
- 12.3 Europe Prophylactic Human Vaccine Market Size Forecast (2021-2026)
- 12.3.1 Europe: Prophylactic Human Vaccine Sales Forecast (2021-2026)
- 12.3.2 Europe: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
- 12.3.3 Europe: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Prophylactic Human Vaccine Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Prophylactic Human Vaccine Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Prophylactic Human Vaccine Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Prophylactic Human Vaccine Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Prophylactic Human Vaccine Sales Forecast (2021-2026)
- 12.5.2 Latin America: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Prophylactic Human Vaccine Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Prophylactic Human Vaccine Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Prophylactic Human Vaccine Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Prophylactic Human Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Prophylactic Human Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Prophylactic Human Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Prophylactic Human Vaccine. Industry analysis & Market Report on COVID-19 Impact on Global Prophylactic Human Vaccine is a syndicated market report, published as COVID-19 Impact on Global Prophylactic Human Vaccine, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Prophylactic Human Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
